Neuromuscular patients management in the COVID era
Neuromuscular diseases are a group of heterogenic rare conditions, that can be due to a genetic cause, inflammatory processes or dysimmune disorders. Pathogenic processes can affect motor neurons, peripheral nerves, neuromuscular junction, or… Continue Reading
Category
COVID-19
-
-
Due to the CoVID-19 pandemic spread, most outpatient facilities have been strictly regulated, thus making it difficult for many patients suffering from chronic pain to access treatment. During this tough period, all pain physicians, including neurologists, are working to find… Continue Reading
-
EAN NewsCOVID-19Top Articles
EAN Movement Disorders Scientific Panel recommendations for COVID-19 pandemic
April 8, 2020The Covid-19 global pandemic is having a dramatic impact on many chronic conditions including those affecting neurological patients and among them those with movement disorders. In many cases, to protect vulnerable movement disorders patients from becoming infected, appointments have been… Continue Reading -
EAN NewsCOVID-19Top Articles
EAN Scientific Panel Neuroscience/Translational neurology Statement on COVID-19
April 8, 2020Specific challenges at present regarding Covid-19 and how these are being addressed
Highly pathogenic coronavirus infections are well-established sources of previous epidemics (severe acute respiratory syndrome coronavirus: SARS‐CoV, Middle East respiratory syndrome coronavirus: MERS‐CoV). Of interest, the novel coronavirus named… Continue Reading -
News from EAN member societiesCOVID-19Top Articles
Frontline Report: Experience from the Spanish Neurologists’ perspective
April 5, 2020Since January 31st, Coronavirus has spread along all the Spanish territory; however, some regions are particularly compromised in terms of number of cases: Madrid, Catalonia, Basque Country and the two Castillian regions. The total number of confirmed cases is about to surpass Italy. We hope to be reaching the plateau of the curve, after all the implemented social distancing measures. -
COVID-19News in general
EMA provides recommendations on compassionate use of remdesivir for COVID-19
April 5, 2020During an extraordinary virtual meeting held on 2 April 2020, EMA’s human medicines committee (CHMP) gave recommendations on how the investigational antiviral medicine remdesivir should be used for treating coronavirus disease (COVID-19) in compassionate use programmes in the European Union. -
The European Reference Netowrk for Epilepsy (EpiCARE) will hold a special webinar on Tuesday, April 7 with experts from Spain and Italy on the change to epilepsy care due to the COVID-19 pandemic.
-
EAN NewsCOVID-19Top Articles
EAN Scientific Panel Infectious diseases: EANCore COVID-19
April 3, 2020Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The virus causes a pneumonia syndrome, with specific and already well-described symptoms, and fatal outcome in a subset of patients. The lungs are… Continue Reading -
Tim J von Oertzen, Ronan McGinty, Martin Holtkamp, Reetta Kalviainen, Stephan Ruegg, Eugen Trinka, Guido Rubboli 3rd April 2020 Physicians of all specialties worldwide are challenged by the new SARS-CoV-2 virus causing corona virus disease 2019 (COVID-19). The virus is… Continue Reading
-
During the Covid-19 pandemic, most European countries have imposed personal restrictions on their populations in order to inhibit viral transmission and spread of infection. The hardest restriction concerns the imposition not to leave home unless to go to the supermarket,… Continue Reading
-
Breaking newsCOVID-19Top Articles
BREAKING NEWS: Guidance on Stroke Managment during COVID-19 Pandemic
April 3, 2020Recently released guidance on stroke management during the current COVID-19 pandemic emphasises carefully managed triage, importance of appropriate personal protective equipment, and crisis resource management. -
EAN NewsCOVID-19Top Articles
The Covid-19 Pandemic in Europe: Challenges, Unanswered Questions, Future Steps: A message from the EAN Epidemiology Panel
April 2, 2020by Ettore Beghi & Daniel Berekzcki An unexpected outbreak due to the infection by the coronavirus, Covid-19, which started in China at the end of 2019, is rapidly expanding and is now officially assigned pandemic status by the WHO. After… Continue Reading -
EAN NewsCOVID-19
Special webinar on ‘Huntington’s disease and the Covid-19 pandemic – a difficult combination’, organized by the European Huntington Association (EHA) and ERN-RND
April 1, 2020Date: 6. April 2020
Time: 16-17:30h CEST To join the webinar please click here:
https://zoom.us/j/284555212
The current situation related to the Covid-19 pandemic causes a lot of strain and isolation in HD patients and their families. All the restrictions imply… Continue Reading -
COVID-19Other NewsTop Articles
World Muscle Society publishes position and advice on Covid-19 and people with neuromuscular disorders
April 1, 2020The World Muslcle Society has recently published its position and advice on the COVID-19 and people with neuromuscular disorders. -
Executive PageEAN NewsCOVID-19Top ArticlesFeatured Slider
EXECUTIVE PAGE: We stand together against COVID-19 pandemic
April 1, 2020Covid-19 has affected over 500,000 people and caused over 21,000 deaths. People from all over the world are making great sacrifices, from social distancing to sustaining economic loss. Healthcare workers are on the frontline, and neurologists are increasingly involved as well.